Good Blood Tests, Bad Capillary Delivery **Absurd Health Institute | Frontier Medical Concept Paper 31 | Volume 8** **Series:** Hydraulics of Disease **Article type:** Causal hypothesis and mechanistic argument; not an original clinical study **Corrective edition:** 17 October 2026 The proposition we defend A normal oxygen saturation is not a certificate of adequate tissue oxygenation. We argue that red-cell transit, capillary density and spatial heterogeneity can create clinically significant delivery failure even when arterial blood chemistry looks reassuring. The relevant unit of oxygen delivery is the functioning tissue microcirculation, not just the sample taken from a large vessel. Normal arterial oxygen saturation and satisfactory hemoglobin do not establish uniform oxygen delivery to every capillary bed. The hypothesis is that local heterogeneity in red-cell traffic, capillary transit and extraction may produce functionally important tissue deficits despite reassuring systemic measurements. Why the mechanism deserves to be taken seriously Oxygen delivery depends on arterial oxygen content, flow, microvascular architecture, diffusion distance and mitochondrial utilization. Capillary transit-time heterogeneity models show how rapid shunting through some channels and slow flow through others can reduce efficient extraction. Endothelial and pericyte regulation, erythrocyte deformability and local inflammation provide mechanisms to consider. The existence of these variables does not establish microvascular ischemia in every fatigued patient. The causal argument Arterial oxygen content depends heavily on hemoglobin and saturation, while local tissue oxygenation also depends on flow distribution, capillary recruitment, transit time and extraction. A region with shunted fast flow or poorly perfused capillaries may receive oxygenated blood yet extract inadequately; another region may stagnate and become hypoxic. Endothelial damage, microthrombi, altered red-cell deformability or edema can disturb microvascular exchange. The core mechanism is heterogeneity: average delivery values conceal regions with insufficient exchange, and large-vessel flow can increase without solving the local defect. Causal architecture under closer examination Oxygen delivery must be interpreted at several scales. Arterial saturation tells us how much of the available hemoglobin is bound to oxygen, but tissue oxygenation also depends on total blood flow, hemoglobin concentration, capillary distribution, diffusion and extraction. A perfectly oxygenated artery may feed a region with inadequate perfusion, and high flow through a small number of capillaries may deliver less useful oxygen than well-distributed flow through an extensive network. Heterogeneous transit times make this point sharper: blood that moves too rapidly through some pathways may not permit optimal extraction even while other cells remain undersupplied. Capillary recruitment and red-cell deformability affect the pattern. But an apparent extraction deficit can also arise downstream when mitochondria cannot use oxygen effectively. Therefore the model must separate delivery, diffusion and utilization rather than treat all three as “poor microcirculation.” The body may compensate at rest, so challenge testing can reveal a deficit that a clinic blood draw misses. This is a plausible route to exertional impairment but not a diagnosis based on fatigue alone. A concrete physiological case Picture a patient with normal pulse oximetry and hemoglobin after a systemic inflammatory illness but persistent exertional intolerance. A microvascular model predicts impaired tissue oxygen extraction or abnormal perfusion heterogeneity on an appropriate challenge. It does not automatically explain all fatigue, and cardiopulmonary disease, autonomic dysregulation and muscle deconditioning remain alternatives. The discriminating examination would measure delivery and utilization under load rather than infer microvascular insufficiency from a normal oxygen saturation alone. What established physiology already supports Microvascular oxygen exchange, capillary transit-time heterogeneity and perfusion heterogeneity have established physiological foundations. The controversial extension is that these spatial abnormalities can act as primary bottlenecks in selected chronic presentations before routine organ-failure measures become abnormal. The strongest counterargument—and the answer The key rival is mitochondrial utilization failure: oxygen may reach tissue but cannot be consumed normally. Another is low total cardiac output. Measuring only reduced extraction cannot distinguish them. A serious test must assess perfusion distribution, local oxygen tension and cellular metabolic response together and compare them against known causes of exercise intolerance. Anemia, heart failure, lung disease, deconditioning and systemic inflammation are often more straightforward causes of reduced exercise tolerance. Microvascular estimates can be model-dependent and differ markedly between brain, muscle and other tissues. The discriminating experiment Use validated imaging or tissue oxygen techniques alongside exercise physiology and red-cell/capillary assessments in narrowly phenotyped groups. Model tissue oxygenation as a distribution, not a single average. The theory predicts persistent underperfused or poorly extracting regions that correlate with performance and respond to microvascular improvement independently of bulk arterial oxygen content. A strong study must demonstrate local extraction abnormalities or perfusion heterogeneity with a validated method, correlate them with region-specific function, and show that altering the abnormality improves outcome. A normal capillary metric in adequately studied symptomatic tissue weakens the hypothesis. Decisive comparisons and limits of inference A robust experiment would measure cardiac output, arterial oxygen content, tissue perfusion distribution and extraction during increasing workloads in a well-characterized subgroup. Resting measurements may be normal even if diffusion reserve is low. An observed fall in tissue oxygenation under load would support an exchange problem only after pulmonary oxygenation, cardiac output and cellular utilization are considered. Regional imaging might demonstrate patches of underperfusion that disappear after a targeted vascular intervention, but normalization of an imaging marker is not enough; exercise capacity or organ performance should improve as well. The model predicts that average arterial metrics poorly discriminate tissue-level risk when microvascular heterogeneity is high. A comparison group with mitochondrial dysfunction but preserved capillary geometry could help distinguish the pathways. The provocative interpretation of the findings would be that routine blood tests summarize the supply side of a supply chain whose final meters remain unmeasured. This is not an argument to distrust normal laboratory results universally; it is an argument that, for certain symptoms and diseases, the question being asked is about a distribution of local oxygen exchange rather than a single average concentration. A second prediction from the original model Local oxygen extraction and capillary transit should add predictive information beyond arterial saturation, cardiac output and hemoglobin. Without an organ-specific measurement, microvascular starvation remains a possibility rather than a patient diagnosis. Why the hypothesis matters if correct This thesis challenges a specific false reassurance: normal blood oxygen saturation and hemoglobin do not prove that every cell receives adequate oxygen under demand. Tissue performance depends on capillary recruitment, transit times, local flow distribution and extraction. A blood test reports upstream supply; it does not directly measure the geometry of delivery. The paper should distinguish this explanation from mitochondrial inability to use oxygen or global reductions in cardiac output. These alternatives can generate similar exertional complaints. A persuasive demonstration would combine microvascular measurements with functional challenge and show that exchange heterogeneity predicts performance after systemic oxygen transport is accounted for. If the hypothesis holds, microvascular disease could produce significant tissue-level deficits before familiar large-vessel or arterial measures become abnormal. The clinical implications would involve developing better tests of regional exchange, not diagnosing microvascular starvation from fatigue alone or offering unvalidated circulatory supplements. The clinical and conceptual consequence The provocative statement is that a normal blood test can coexist with a starving tissue because delivery has a geometry. It invites measurement of exchange at the scale where cells live, rather than more elaborate interpretation of a reassuring arterial number. Clinically, a normal pulse-oximeter reading should not end the evaluation of serious ischemia or tissue injury; equally, it is no warrant for speculative oxygen therapies without a demonstrated indication. Clinically, a normal pulse-oximeter reading should not end the evaluation of serious ischemia or tissue injury; equally, it is no warrant for speculative oxygen therapies without a demonstrated indication. Source bibliography: verification pending - [Angleys H et al. The effects of capillary transit time heterogeneity on brain oxygenation. J Cereb Blood Flow Metab. 2015.](https://pmc.ncbi.nlm.nih.gov/articles/PMC4420854/) Editorial and clinical boundaries This paper advances a causal thesis and identifies observations that would support or defeat it. It does not establish a new diagnosis or treatment, and it should not be used to discontinue medically indicated care. Bibliographic entries inherited from the original edition have not all been independently verified.